Lansdale, PA, United States of America

John E MacNair

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of John E. MacNair

Introduction

John E. MacNair is a notable inventor based in Lansdale, PA (US), recognized for his contributions to the field of immunology and vaccine development. With a total of three patents to his name, MacNair has made significant strides in the production of polysaccharide-protein conjugates, which are crucial for developing effective vaccines.

Latest Patents

MacNair's latest patents include innovative methods for producing capsular polysaccharide protein conjugates from serotype 19F. This invention provides a method of producing a polysaccharide-protein conjugate with capsular polysaccharide from serotype 19F conjugated to a carrier protein. The method includes a prolonged incubation step prior to filtration to remove free polysaccharide. Another significant patent involves immunogenic compositions that utilize diphtheria toxin fragment B as a carrier. This invention provides compositions having one or more polysaccharide-protein conjugates in which polysaccharides obtained from bacterial capsules are conjugated to diphtheria toxin fragment B (DTFB) or a variant thereof. These immunogenic compositions may be multivalent pneumococcal polysaccharide conjugate compositions.

Career Highlights

John E. MacNair is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work focuses on developing innovative solutions in the field of vaccines and immunology, contributing to advancements that can improve public health.

Collaborations

MacNair has collaborated with notable colleagues, including Michael Albert Winters and William J. Smith, to further enhance the research and development of immunogenic compositions.

Conclusion

John E. MacNair's contributions to the field of immunology through his patents and work at Merck Sharp & Dohme Corporation highlight his role as an influential inventor. His innovative methods for producing polysaccharide-protein conjugates are paving the way for advancements in vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…